Loading companies…
Loading companies…
United States · Healthtech · Biotech
Develops preventive RNAi medicines for cardiovascular disease prediction and prevention
| Announced | Round | Amount | Investors |
|---|---|---|---|
| Series A | $80M | Forbion — Role not disclosedPopulation Health Partners — Role not disclosed |